Open AccessP888: REPLACING STEROIDS IN TRANSPLANT‐INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB‐BORTEZOMIB‐LENALIDOMIDE‐DEXAMETHASONE REST STUDY
Author(s) -
Askeland F. B.,
Haukås E.,
Slørdahl T. S.,
Schjøll D.,
Lysen A.,
Hermansen E.,
Schjesvold F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846428.64094.91
Subject(s) - lenalidomide , dexamethasone , medicine , bortezomib , multiple myeloma , oncology , pomalidomide , carfilzomib , autologous stem cell transplantation , melphalan , transplantation , pharmacology